AstraZeneca has opened its first U.S.-operated cell therapy manufacturing plant in Rockville, Maryland, as part of its ...

The investment strengthens Maryland’s position as a biotech hub and reflects AstraZeneca’s commitment to local job creation ...

As it applies to the development of cell therapies, AstraZeneca’s chief of global operations, Pam Cheng, admits that the ...

Cell therapy is considered by some as the next frontier in cancer treatment, engineering patients' own immune systems to ...

AstraZeneca opened a $300M CAR-T cell therapy facility in Rockville, boosting Maryland's life sciences sector and creating ...

Larry Hogan speaks to members of the media at the AstraZeneca facility in Gaithersburg, Md., on Aug. 26, 2024. Larry Hogan ...

The facility is part of AstraZeneca's $3.5 billion investment in U.S. research and manufacturing.

The facility to manufacture cell therapies for cancer research is part of the company's push to invest $3.5B in its U.S.

The British pharma giant's expansion in Montgomery County comes at a crucial time for the local biotech sector. New Md. hospital could break ground next year — with ...

The facility, which will produce cell therapies used to treat cancer and auto immune diseases, creates 150 jobs for highly ...

Larry Hogan speaks to members of the media at the AstraZeneca facility in Gaithersburg, Md., on Aug. 26, 2024. Larry Hogan speaks to members of the media at the AstraZeneca facility in ...

AstraZeneca, as part of its ongoing $3.5 billion investment in American innovation, opened its first U.S.-operated cell therapy factory in Maryland to help treat cancer patients. The U.K-based ...